- জেনেরিক নাম
- Tranexamic Acid
- শক্তি
- 250 mg/5 ml
- ডোজ ফর্ম
- Injection
- প্রস্তুতকারক
- Advanced Chemical Industries PLC
Anaxyl Injection
Anaxyl 250 mg/5 ml Injection সম্পর্কে
বাংলাদেশে Anaxyl 250 mg/5 ml Injection ইনজেকশন হিসেবে পাওয়া যায়; এতে Tranexamic Acid আছে (২৫০ mg/৫ ml)। Anaxyl প্রস্তুত করেছে Advanced Chemical Industries PLC। Anaxyl-এর সাথে Tranexamic Acid-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। ডাক্তারের প্রেসক্রিপশন মেনে চলুন এবং অন্য ব্র্যান্ড খাওয়া যাবে কি না তা ফার্মাসিস্টের কাছ থেকে জেনে নিন।
Tranexamic Acid-এর ৩৫টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। সবচেয়ে কম দাম Enclot 250 mg Capsule-এর, প্রতি ইউনিট ৳ ৮.০৬।
Anaxyl 250 mg/5 ml Injection কী?
Anaxyl Injection is a product of Advanced Chemical Industries PLC. It contains tranexamic acid, which belongs to a group called anti-fibrinolytic drugs. These medicines work against the breakdown of blood clots, which is how they help limit bleeding in some situations. The injection is available in the strength 250 mg/5 ml and is given by a healthcare professional. It is used in certain bleeding conditions in medicine and around surgery. The decision to use it, and the dose and course, is made by the doctor.
Anaxyl-এর ব্যবহার
Anaxyl Injection is used in certain bleeding problems where excessive clot breakdown plays a part. These include some bleeding in the lungs and digestive tract, bleeding linked to certain blood and liver conditions, and bleeding during and after operations of various types. Only a doctor can decide whether this medicine is appropriate. Ask the doctor about what it is being used for in a particular case.
Anaxyl কীভাবে ব্যবহার করবেন
Anaxyl Injection is given by a healthcare professional, usually into a vein or a muscle. You should not give it to yourself. The doctor decides the dose, how it is given and how long treatment continues. Tell the doctor about any other medicines being taken and about any kidney problems before it is given. Ask the doctor or pharmacist if you have questions about the course of treatment.
Anaxyl-এর পার্শ্বপ্রতিক্রিয়া
Anaxyl Injection is generally well tolerated, but some people may notice effects such as tiredness, eye irritation, a blocked nose, itching, skin redness or a rash. Rarely, a fall in blood pressure on standing has been reported. If there are signs of an allergic reaction, treatment should be stopped and appropriate care started. Tell the doctor or nurse about any unusual symptoms during or after the injection.
সতর্কতা ও নিরাপত্তা
Anaxyl Injection should not be used by anyone with a known allergy to tranexamic acid, a history of blood clots in arteries or veins, certain internal bleeding, or serious kidney failure. It is used with caution in milder kidney problems. Because its effects on an unborn baby are not known, it should not be given during known or suspected pregnancy. It passes into breast milk in small amounts, and an effect on the baby is considered unlikely. Always ask the doctor first about pregnancy, breastfeeding and other health conditions.
সাধারণ প্রশ্ন
What kind of medicine is Anaxyl Injection and what is it used for?
It is an anti-fibrinolytic injection containing tranexamic acid. It is used in certain bleeding conditions in medicine and around surgery, where excessive clot breakdown plays a part. The doctor decides whether it is suitable for a particular person.
Which medicines may interact with Anaxyl Injection?
It is incompatible with solutions containing penicillins, and thrombolytic drugs such as streptokinase and urokinase can oppose its action. Estrogen-containing medicines like oral contraceptives may raise the potential for clot formation. Mixing it directly with whole blood during transfusion should be avoided. Tell the doctor about all medicines being taken.
Is Anaxyl Injection safe in pregnancy or breastfeeding?
It should not be given during known or suspected pregnancy, because its effects on the unborn baby are not known. It passes into breast milk in small amounts, and an effect on the baby is considered unlikely. Ask the doctor before use if pregnant or breastfeeding.
Who should ask a doctor before Anaxyl Injection is used?
Anyone with a history of blood clots, kidney problems, or an allergy to tranexamic acid should tell the doctor first. People who are pregnant or breastfeeding should also check with the doctor. The doctor decides whether the injection is appropriate.
নির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
In medicine: Prophylaxis and therapy of hemophtoes, digestive hemorrhages, hemorrhagic syndromes in leukaemia, cirrhosis and hemophilia, thrombocytopenic purpura, accidents during thrombolytic therapy and transfusion.In surgery: Prophylaxis and antihemorrhagic ... Read moreIn medicine: Prophylaxis and therapy of hemophtoes, digestive hemorrhages, hemorrhagic syndromes in leukaemia, cirrhosis and hemophilia, thrombocytopenic purpura, accidents during thrombolytic therapy and transfusion.
In surgery: Prophylaxis and antihemorrhagic therapy during operations of any type and nature and particularly in pulmonary, cardiovascular and abdominal surgery and post-operative and traumatic shock.
In urology: Prophylaxis and antihemorrhagic therapy of prostatic, vesical and renal surgery. Hematurias.
In obstetrics: Prophylaxis and therapy of post-partum and puerperium hemorrhages, hemorrhagic metrophathies, functional menometrorrhagias, idiopathic or IUD(lntra uterine Device) induced menorrhagias, primitive hyperfibrinolysis (abruptio placentae, premature placenta detachment) and in cervical conization.
In otorhinolaryngology: Prophylaxis and antihemorrhagic therapy during a tonsillectomy, specialist surgery generally, epistaxis.
In stomatology: Prophylaxis and antihemorrhagic therapy during maxillofacial operations, tooth extractions.
In oncology (as supportive therapy): To promote the formation of a fibrin capsule to wall off and thereby inhibit the growth of ovarian tumors. To cause regression of ascites secondary to carcinoma. To reduce bleeding during surgical interventions.
ফার্মাকোলজি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
This is a preparation of tranexamic acid (trans-4 aminomethyl-cyclohexanecarboxylic acid). Tranexamic acid is a substance endowed with a strong antifibrinolytic action and both in vivo and in vitro it has proved to be 10 times more active than conventional hemostatics, depending on the test. The antihemorrhagic action of tranexamic acid is essentially due to an inhibition of the plasminogen activation of both exogenous activators like streptokinase and endogenous ones like urokinase and the plasminogen tissue activator. This fact is particularly important for the clinical use of Tranexamic Acid, because it ensures an antihemorrhagic activity with an antifibrinolytic mechanism under a variety of conditions.The acute toxicity of Tranexamic Acid is extremely low and chronic toxicity almost non-existent. Tranexamic Acid is well absorbed by oral route and the effect is already seen 15-30 minutes after administration. It is excreted mainly by renal route but more slowly than conventional hemostatics. These features make the Tranexamic Acid effect more lasting than those conventional hemostatics. Considerably lower single doses of Tranexamic Acid can thus be administered at greater intervals without the drug plasma levels dropping to inefficient levels of antifibrinolytic activity between one dose and the other.
Tranexamic Acid at therapeutic doses does not interfere with clotting processes and even a prolonged administration has not been seen to be accompanied by any tendency to thrombophilia.
মাত্রা ও সেবনবিধি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Adults-- The usual dose: 500-1000 mg 3 times daily.
- For prophylaxis: The mean recommended daily doses are 0.5-1 gm orally, 500 mg by the parenteral (intravenous or intramuscular) route.
- For therapy of hemorrhagic manifestations: the oral dose increases to 1-3 gm given in divided doses: in cases of particular seriousness and urgency, begin by injecting an ampoule (500 mg) slowly by intravenous route and administer the necessary subsequent oral doses.
- For prophylaxis: For every kg of body weight from 5-10 mg are orally administered daily in divided doses.
- For therapeutic purposes: The oral doses are doubled (from 10 to 20 mg/kg), while the intravenous and intramuscular treatment is begun with 10 mg/kg (=0.5 ml every 5 kg) by the slow intravenous route, continuing the oral administration up to the required dose. Where it is more convenient (e.g. in small babies) the ampoules, diluted in a little sweetened water, maybe orally administered instead of the Capsules.
ঔষধের মিথষ্ক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Tranexamic Acid is a synthetic Amino Acid that is incompatible with solutions containing penicillins (eg: Benzyl penicillin). Thrombolytic drugs like Streptokinase & Urokinase antagonise the antifibrinolytic action of Tranexamic Acid. The potential for thrombus formation may be increased by concomitant administration of estrogen containing drugs, like oral contraceptives. Direct admixture of Tranexamic Acid with whole blood should be avoided during Transfusion.প্রতিনির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Known individual hypersensitivity to the product. Thromboembolic disease, arterial and venous thrombosis, endocavitary hemorrhages, serious kidney failure.পার্শ্ব প্রতিক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
- Tranexamic Acid is generally well tolerated; there may be infrequent cases of sense of fatigue, conjunctival irritation, nasal blockage, itching, skin reddening, exanthems.
- After oral administration there may be sign of nausea, diarrhea, gastric pyrosis.
- There are rare cases of postural hypotension.
- In the case of hypersensitivity to tranexamic acid, avoid or suspend treatment and start a suitable therapy.
গর্ভাবস্থায় ও স্তন্যদানকালে
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Since the transplacental passage of the drug and its possible effects on the fetus are unknown, Tranexamic Acid should not be administered during known and presumed pregnancy. Tranexamic Acid passes into breast milk to a concentration of approximately one hundredth of the concentration in the maternal blood. An antifibrinolytic effect in the infant is unlikely.সতর্কতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
- Tranexamic Acid should be used in cases where there is hyperfibrinolysis. The prophylactic treatment must begin 24 hours before the operation and continue until 3-4 days after it.
- The therapy of hemorrhages must be prolonged for at least 24 hours after manifestations have disappeared.
- In hematuria, especially when this is not accompanied by any other hemorrhagic manifestations, reduce the doses to prevent formation of clots in the urinary tract.
- Tranexamic Acid must not be used in serious renal insufficiency or anuric syndromes and must only be used with caution in less serious renal dysfunctions.
- The administration of product requires particular care in cardiopathic and hepatopathic subjects.
সংরক্ষণ
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Store in a dry place at 15-30°C, away from light and keep out of children's reach.বিকল্প ব্র্যান্ড: Tranexamic Acid
একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।